+1
with emphasis,
@whytee has nailed a strong summary and reason followers of the science:
"Right now though the market knows plans for commercialisation have been shelved and possibly concluded that NTcell "doesn't work." I think the second part is premature, since 3 of the first 4 patients do seem to have had a sustained durable response now over several years.
"I [too] belong to the group that believes [1] that embryological dopaminergic implants have been shown to work provided that the treatment is given before global damage is too severe, and [2] that side effects can be limited by not implanting an excessive number of dopaminergic cells and [3] the cells are implanted by distributing them uniformly along the length of the putamen."
I suspect the intention of going to market has not been shelved, just yet, even tho the application has had to be put on hold
I think we bang the "time" drum for as long as it takes as time seems to be the crucial fulcrum nearly everywhere i look including ncbi studies, the door remains widely open
- Forums
- ASX - By Stock
- 1AI
- research v. Phase II exam
research v. Phase II exam, page-13
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $23.34K | 3.334M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 3931572 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 4990 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 3931572 | 0.006 |
14 | 7943716 | 0.005 |
6 | 5095009 | 0.004 |
3 | 3800000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 4990 | 1 |
0.008 | 1669135 | 6 |
0.009 | 869315 | 6 |
0.010 | 2413365 | 3 |
0.011 | 90000 | 1 |
Last trade - 10.59am 11/11/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
SPONSORED BY The Market Online